Cerity Partners’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.6K Buy
38,143
+9,307
+32% +$12.8K ﹤0.01% 3301
2026
Q1
$37.2K Buy
28,836
+16,472
+133% +$27.2K ﹤0.01% 3137
2025
Q4
$27.3K Buy
+12,364
New +$23.2K ﹤0.01% 2834

Other funds holding LUNG

Cerity Partners's LUNG Position: Q2 2026 in Review

Cerity Partners increased its Pulmonx (LUNG) stake by 32% in Q2 2026, buying an estimated $12.8K and bringing the position to 38,143 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3301.

Cerity Partners first reported a position in LUNG in Q4 2025 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Cerity Partners held 38,143 shares of Pulmonx worth $49.6K as of Q2 2026.
  • Cerity Partners bought 9,307 Pulmonx shares in Q2 2026, an estimated $12.8K.
  • Pulmonx made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3301 holding.
  • Cerity Partners first reported a position in Pulmonx in Q4 2025 and has held it in 3 quarters since.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.